0.90
-0.0515(-5.41%)
Currency In USD
| Previous Close | 0.95 |
| Open | 0.98 |
| Day High | 0.99 |
| Day Low | 0.9 |
| 52-Week High | 4.84 |
| 52-Week Low | 0.8 |
| Volume | 115,461 |
| Average Volume | 219,886 |
| Market Cap | 8.76M |
| PE | -1.31 |
| EPS | -0.69 |
| Moving Average 50 Days | 1.12 |
| Moving Average 200 Days | 1.44 |
| Change | -0.05 |
If you invested $1000 in Bullfrog AI Holdings, Inc. Common Stock (BFRG) since IPO date, it would be worth $138.54 as of December 30, 2025 at a share price of $0.901. Whereas If you bought $1000 worth of Bullfrog AI Holdings, Inc. Common Stock (BFRG) shares 1 year ago, it would be worth $414.98 as of December 30, 2025 at a share price of $0.901.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights
GlobeNewswire Inc.
Nov 18, 2025 2:00 PM GMT
New publication details how BullFrog Data Networks® and bfLEAP® technology address fundamental AI challenges in drug discovery and developmentGAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("Bu
BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025
GlobeNewswire Inc.
Nov 12, 2025 1:00 PM GMT
Technical insights session to highlight human-in-the-loop AI agent workflows in drug developmentGAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-ena
BullFrog AI Announces Abstract Accepted for Presentation at 2026 ASCO Gastrointestinal Cancers Symposium
GlobeNewswire Inc.
Nov 04, 2025 1:00 PM GMT
AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide Accepted ASCO abstract, submitted in collaboration with Eleison Pharmaceuticals, provides further validation of BullFrog AI’s technolog